OVIT (OncoVista Innovative Therapies) Non Operating Income: $0.16 Mil (TTM As of Sep. 2015)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OncoVista Innovative Therapies Non Operating Income?

OncoVista Innovative Therapies OVIT Non Operating Income is $0.16 Mil as of Sep. 2015.

Non Operating Income is income or expense that comes from miscellaneous sources. OncoVista Innovative Therapies's Non Operating Income for the three months ended in Sep. 2015 was $0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2015 was $0.16 Mil.


OncoVista Innovative Therapies Non Operating Income Related Terms


OncoVista Innovative Therapies Non Operating Income Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Non Operating Income Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 -0.01 0.36 0.07 0.01

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.16 0.00 0.00 0.00

OncoVista Innovative Therapies Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of $0.16 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Non Operating Income of $0.16 Mil as of Sep. 2015. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Non Operating Income too high?
OncoVista Innovative Therapies' current Non Operating Income is $0.16 Mil.
How does OncoVista Innovative Therapies' Non Operating Income compare to RSPI and HSTC?
OncoVista Innovative Therapies' Non Operating Income of $0.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Biotechnology company?
A good Non Operating Income depends on the Biotechnology industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Non Operating Income is $0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Non Operating Income of $0.16 Mil. The current Non Operating Income is $0.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Non Operating Income is $0.16 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.